Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024312 (
lymphopenia
)
4,859
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disorder characterized by blood vessel occlusions, acral necrosis, myositis, rashes, and pulmonary inflammation that are the result of activating mutations in the STimulator of Interferon Genes (STING). We generated a transgenic line that recapitulates many of the phenotypic aspects of SAVI by targeting the expression of the human STING-N154S-mutant protein to the murine hematopoietic compartment.
hSTING
-N154S
mice demonstrated failure to gain weight,
lymphopenia
, progressive paw swelling accompanied by inflammatory infiltrates, severe myositis, and ear and tail necrosis. However, no significant lung inflammation was observed. X-ray microscopy imaging revealed vasculopathy characterized by arteriole occlusions and venous thromboses. Type I interferons and proinflammatory mediators were elevated in
hSTING
-N154S
sera. Importantly, the phenotype was prevented in
hSTING
-N154S
mice lacking the type I interferon receptor gene (
Ifnar1
). This model, based on a mutant human STING protein, may shed light on the pathophysiological mechanisms operative in SAVI.
...
PMID:Expression of a constitutively active human
STING
mutant in hematopoietic cells produces an
Ifnar1
-dependent vasculopathy in mice. 3122 25